2018 HF Board Review Course

20 - Heart Transplant, Clinical Outcomes and Complications

Aug 18, 2018 10:45am ‐ Aug 18, 2018 11:15am

Credits: None available.


  • James Fang, MD, FHFSA, Professor of Medicine, University of Utah Health Sciences


  • James Fang, MD, FHFSA:
    • Consultant-Advisory Board- Novartis; Agmen; Capricor; Johnson & Johnson; AHA; NIH
    • Institution- University of Utah


Credits: None available.

You must be logged in and own this session in order to post comments.